226 related articles for article (PubMed ID: 19232956)
1. Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.
Moos MP; Funk CD
Trends Cardiovasc Med; 2008 Oct; 18(7):268-73. PubMed ID: 19232956
[TBL] [Abstract][Full Text] [Related]
2. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
3. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Ni NC; Ballantyne LL; Mewburn JD; Funk CD
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
[TBL] [Abstract][Full Text] [Related]
4. The role of cysteinyl-LT(1)receptor (CysLT(1)R) in renal ischemia-reperfusion injury.
Matsuyama M; Funao K; Chargui J; Touraine JL; Nakatani T; Yoshimura R
Transplant Proc; 2009; 41(1):73-5. PubMed ID: 19249480
[TBL] [Abstract][Full Text] [Related]
5. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene signaling in atherosclerosis and ischemia.
Bäck M
Cardiovasc Drugs Ther; 2009 Feb; 23(1):41-8. PubMed ID: 18949546
[TBL] [Abstract][Full Text] [Related]
9. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
10. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
11. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia.
Fang SH; Zhou Y; Chu LS; Zhang WP; Wang ML; Yu GL; Peng F; Wei EQ
Neurosci Lett; 2007 Jan; 412(1):78-83. PubMed ID: 17196746
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
Rubin P; Mollison KW
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
[TBL] [Abstract][Full Text] [Related]
13. Study of cysteinyl leukotriene-1 receptor in rat renal ischemia-reperfusion injury.
Matsuyama M; Funao K; Kawahito Y; Sano H; Chargui J; Touraine JL; Takemoto Y; Nakatani T; Yoshimura R
Transplant Proc; 2008 Sep; 40(7):2149-51. PubMed ID: 18790177
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.
Jiang W; Hall SR; Moos MP; Cao RY; Ishii S; Ogunyankin KO; Melo LG; Funk CD
Am J Pathol; 2008 Mar; 172(3):592-602. PubMed ID: 18276782
[TBL] [Abstract][Full Text] [Related]
15. [Adhesive molecules as drugs and objects of pharmacological effect in myocardial ischemia and reperfusion].
Uteshev DB; Uteshev BS
Eksp Klin Farmakol; 1997; 60(3):83-8. PubMed ID: 9324410
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.
Corrigan C; Mallett K; Ying S; Roberts D; Parikh A; Scadding G; Lee T
J Allergy Clin Immunol; 2005 Feb; 115(2):316-22. PubMed ID: 15696087
[TBL] [Abstract][Full Text] [Related]
17. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene modifiers in the treatment of cardiovascular diseases.
Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
[TBL] [Abstract][Full Text] [Related]
20. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.
Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE
Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
